LifeStance Health (Nasdaq: LFST) is overhauling its facilities with a new operating model — one that it hopes will strengthen its position ahead of what executives expect to be a rocky 2025. The outpatient mental health giant’s executives project that federal reimbursement rate cuts will challenge the company’s financial progress. LifeStance is banking on momentum […]
Previous research has consistently demonstrated that cannabis use among adolescents contributes to symptoms of psychosis, but the exact reasons have remained unclear. Researchers have now identified that external factors and self-medication likelihood play a part in increased psychotic symptoms, according to a new study published in JAMA Psychiatry. The study’s authors recommend that their findings […]
Sabra Health Care REIT (Nasdaq: SBRA) is less enthusiastic about doing deals in the behavioral health space. Leaders of the Tustin, California-based health care real estate investment trust (REIT) said they no longer see the same opportunity to diversify portions of their portfolio to behavioral health uses. The company has also identified few prospective behavioral […]
Outcomes data has been touted as both the key to value-based care and the best leverage SUD providers have in payer negotiations. A handful of providers are seeing that in reality: Some payers are becoming amenable in negotiations when outcomes data is on the table, industry insiders said at the Behavioral Health Business INVEST conference. […]
The National Quality Forum (NQF) has partnered with a coalition of health plans and the national digital therapy enablement platform Headway to create a new assessment tool that standardizes how behavioral health clinicians measure the progress of care. The behavioral health industry, across specialties, has struggled with a lack of a standardized data measurement set. […]
Almost 10% of Americans will experience a depressive illness in their life. Despite depression’s prevalence, the burgeoning digital therapeutics (DTx) industry had, until recently, not made a dedicated attempt to treat the illness. Now, pharmaceutical giant Otsuka’s (OTCMKTS:OTSKY) company, Otsuka Precision Health, has created the first FDA-approved digital therapeutic designed to treat depression alongside an […]
Bad news at Acadia Healthcare (Nasdaq: ACHC) has translated into a real financial impact. The behavioral health behemoth experienced lower patient volume growth than expected in October, which company leadership attributed to bad press in its Q3 earnings call. Acadia expects the negative impact to be temporary, according to Heather Dixon, Acadia’s chief financial officer. […]
Teladoc (NYSE: TDOC) is defending the basic premise of its BetterHelp business model while presenting drooping third-quarter revenue figures. But the company plans to continue to invest in its capabilities to stay afloat in a rapidly changing, competitive industry. “We view 2025 as being an important repositioning year for the company as we execute against […]
Macroeconomic factors, including interest rates and inflation, are beginning to improve, creating tailwinds for the substance use disorder (SUD) treatment industry. Lingering impacts of now-improving economic turbulence will continue to affect the industry, however. In turn, investors have had to become more disciplined, industry experts said at the Behavioral Health Business INVEST conference. Operators, meanwhile, […]
A large, federally funded study focused on reducing opioid overdose deaths highlighted mixed results. Community-focused interventions, including naloxone distribution and increased education, can be effective at reducing overdose deaths that involve an opioid and a psychostimulant other than cocaine, according to a study published in JAMA Network Open. However, the same interventions were found to […]